Krishna Institute of Medical Sciences (KIMS) — Board Meeting

KIMS issued a corrigendum to its EGM notice dated 15 June 2026, clarifying updated debt figures in the preferential issue disclosure and adding language confirming promoter status of allottees. The revised amounts for outstanding loans to KIMS Hospital Bengaluru and Arunodaya Hospitals are ₹2,27,91,60,879 and ₹69,87,99,104 respectively, with a total of ₹3,42,79,59,983. The corrigendum also updates paragraph 20 to explicitly state that Dr. Abhinay Bollineni, Mr. Adwik Bollineni, and Bharas Ventures LLP will remain promoters post-preferential issue. The document is available on KIMS, BSE, NSE, and MUFG Intime websites.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KIMS ✨ Ask AI About This

About Krishna Institute of Medical Sciences Limited (KIMS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹30,476.58 Cr P/E: 80.3

View full KIMS stock details →

📡 Get AI alerts when KIMS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KIMS — Free

💡 Ask AI about this filing

"How does this board meeting affect Krishna Institute of Medical Sciences Limited's outlook?" "What did Krishna Institute of Medical Sciences Limited announce on 4 July 2026?" "Is this positive or negative for KIMS?"

Ask AI Free →

📊 More KIMS filings

See all KIMS filings →

🔥 Also filed on 4 July 2026

RAINBOW Rainbow Childrens Medicare Limited Annual Report RAJRATAN Rajratan Global Wire Limited Annual Report RITES RITES Limited Announcement RSL Rajputana Stainless Limited Announcement SALASAR Salasar Techno Engineering Limited Corporate Action RAINBOW Rainbow Childrens Medicare Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KIMS files new disclosures

Track KIMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.